Pharming Group NV (PHAR)
17.57
+0.23
(+1.33%)
USD |
NASDAQ |
Apr 20, 16:00
17.55
-0.02
(-0.11%)
Pre-Market: 20:00
Pharming Group EPS Diluted (Quarterly) : 0.0699 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| uniQure NV | -0.5949 |
| ProQR Therapeutics NV | -0.1008 |
| argenx SE | -- |
| Pharvaris NV | -0.8343 |
| NewAmsterdam Pharma Co. NV | -0.6549 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.296M |
| Revenue (Quarterly) | 106.42M |
| Total Expenses (Quarterly) | 101.12M |
| Enterprise Value | 1.140B |
| Gross Profit Margin (Quarterly) | 77.18% |
| Profit Margin (Quarterly) | 4.98% |
| Earnings Yield | 0.17% |
| Operating Earnings Yield | 2.39% |
| Normalized Earnings Yield | 0.7655 |